Fenwick Represents Arine in $30M Series C Funding

Fenwick represented Arine, an artificial intelligence-enabled medication management company, in its $30 million Series C financing. The round was led by Town Hall Ventures with participation from Kaiser Permanente Ventures.

Arine will use the funds to enhance the AI platform, which includes expanding its capabilities in specialty medication management. Additional information can be obtained here.

The Fenwick transaction team was led by corporate partners Michael Esquivel and Patrick Grilli and included associates Serena Ward and Michael Murrietta.